339 related articles for article (PubMed ID: 29633898)
1. Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors.
Daskalakis M; Brocks D; Sheng YH; Islam MS; Ressnerova A; Assenov Y; Milde T; Oehme I; Witt O; Goyal A; Kühn A; Hartmann M; Weichenhan D; Jung M; Plass C
Cell Cycle; 2018; 17(7):811-822. PubMed ID: 29633898
[TBL] [Abstract][Full Text] [Related]
2. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells.
Xu S; Ren J; Chen HB; Wang Y; Liu Q; Zhang R; Jiang SW; Li J
Curr Pharm Des; 2014; 20(11):1881-7. PubMed ID: 23888960
[TBL] [Abstract][Full Text] [Related]
3. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
Fandy TE
Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death.
Beyer U; Krönung SK; Leha A; Walter L; Dobbelstein M
Cell Death Differ; 2016 Jan; 23(1):64-75. PubMed ID: 26024393
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases and epigenetic therapies of hematological malignancies.
Mercurio C; Minucci S; Pelicci PG
Pharmacol Res; 2010 Jul; 62(1):18-34. PubMed ID: 20219679
[TBL] [Abstract][Full Text] [Related]
6. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
7. HDAC modulation and cell death in the clinic.
Dell'Aversana C; Lepore I; Altucci L
Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Control of Human Endogenous Retrovirus Expression: Focus on Regulation of Long-Terminal Repeats (LTRs).
Hurst TP; Magiorkinis G
Viruses; 2017 May; 9(6):. PubMed ID: 28561791
[TBL] [Abstract][Full Text] [Related]
9. Exploiting histone deacetylases for cancer therapy: from hematological malignancies to solid tumors.
Huang M; Geng M
Sci China Life Sci; 2017 Jan; 60(1):94-97. PubMed ID: 27888384
[No Abstract] [Full Text] [Related]
10. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors in hematological malignancies and solid tumors.
Chun P
Arch Pharm Res; 2015 Jun; 38(6):933-49. PubMed ID: 25653088
[TBL] [Abstract][Full Text] [Related]
12. The future of epigenetic therapy in solid tumours--lessons from the past.
Azad N; Zahnow CA; Rudin CM; Baylin SB
Nat Rev Clin Oncol; 2013 May; 10(5):256-66. PubMed ID: 23546521
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors.
Díaz-Carballo D; Saka S; Acikelli AH; Homp E; Erwes J; Demmig R; Klein J; Schröer K; Malak S; D'Souza F; Noa-Bolaño A; Menze S; Pano E; Andrioff S; Teipel M; Dammann P; Klein D; Nasreen A; Tannapfel A; Grandi N; Tramontano E; Ochsenfarth C; Strumberg D
Commun Biol; 2021 Mar; 4(1):276. PubMed ID: 33658617
[TBL] [Abstract][Full Text] [Related]
14. Reversing aberrant methylation patterns in cancer.
Poke FS; Qadi A; Holloway AF
Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939
[TBL] [Abstract][Full Text] [Related]
15. Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats.
Schön U; Seifarth W; Baust C; Hohenadl C; Erfle V; Leib-Mösch C
Virology; 2001 Jan; 279(1):280-91. PubMed ID: 11145909
[TBL] [Abstract][Full Text] [Related]
16. Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses.
Sokol M; Jessen KM; Pedersen FS
APMIS; 2016; 124(1-2):127-39. PubMed ID: 26818267
[TBL] [Abstract][Full Text] [Related]
17. [Histone deacetylase inhibitors - molecular mechanisms of actions and clinical applications].
Grabarska A; Dmoszyńska-Graniczka M; Nowosadzka E; Stepulak A
Postepy Hig Med Dosw (Online); 2013 Aug; 67():722-35. PubMed ID: 24018438
[TBL] [Abstract][Full Text] [Related]
18. Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation.
Peng Z; Zhou W; Zhang C; Liu H; Zhang Y
Med Sci Monit; 2018 Jan; 24():461-472. PubMed ID: 29363667
[TBL] [Abstract][Full Text] [Related]
19. Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer.
Bai Y; Ahmad D; Wang T; Cui G; Li W
Curr Top Med Chem; 2019; 19(12):995-1004. PubMed ID: 30686256
[TBL] [Abstract][Full Text] [Related]
20. Functional human endogenous retroviral LTR transcription start sites are located between the R and U5 regions.
Kovalskaya E; Buzdin A; Gogvadze E; Vinogradova T; Sverdlov E
Virology; 2006 Mar; 346(2):373-8. PubMed ID: 16337666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
